文献速递头颈外科

唾液腺腺样囊性癌术后治疗中的差异

Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas.
PubMed 文献 · Laryngoscope · 2018-09-08

该研究基于美国国家癌症数据库2004至2014年数据,纳入3136例非转移性、根治性切除的唾液腺腺样囊性癌患者,评估术后放疗和/或化疗的预测因素。结果显示71.8%接受术后放疗,7.4%同时接受化疗;黑人患者和未保险患者接受放疗的可能性较低。术后放疗或化疗与总生存无关联,但随访时间有限。

要点

  • 根治性切除的ACC患者中71.8%接受术后放疗,7.4%接受同步化疗。
  • 黑人患者和未保险患者接受术后放疗的可能性较低。
  • 术后放疗或化疗与总生存无显著关联,但随访时间较短。

核心结论

  • 术后放疗在切除的ACC中频繁使用,少数接受化疗;黑人和未保险患者接受放疗的可能性较低。
  • 术后放疗和/或化疗与总生存无关联,但在更晚期疾病中使用频率更高,系列受限于短随访。

研究设计与样本

  • 回顾性队列研究,查询美国国家癌症数据库2004至2014年根治性切除的非转移性ACC患者,共3136例。
  • 使用逻辑回归、Kaplan-Meier和Cox比例风险模型,并采用倾向评分匹配分析减少混杂变量。

主要发现

  • 2252例(71.8%)接受术后放疗,其中223例(7.4%)同时接受同步化疗。
  • 中位随访时间为4.87年。
  • 临床淋巴结阴性(cN0)患者中,选择性颈清扫后7.4%有病理阳性淋巴结。
  • 居住地离治疗机构较近和切缘阳性的患者更可能接受术后放疗。
  • 黑人患者和未保险患者接受放疗的可能性较低;年龄较大、男性、分期进展和切缘阳性与较差的总生存相关。

临床怎么用

  • 对于根治性切除的非转移性ACC,术后放疗常用,但需注意黑人和未保险患者可能面临治疗差异。
  • 临床淋巴结阴性患者可考虑选择性颈清扫以发现隐匿性淋巴结转移。

局限性

  • 随访时间有限,可能影响生存关联的评估。
  • 回顾性数据库研究,存在未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The patterns of care for salivary gland adenoid cystic carcinomas (ACC) are unknown. We sought to assess predictors of receiving postoperative radiation and/or chemotherapy for patients with nonmetastatic, definitively resected ACC, as well as report unexpected nodal disease. METHODS: The National Cancer Data Base was queried for definitively resected nonmetastatic ACC from 2004 to 2014. Logistic regression, Kaplan-Meier, and Cox proportional-hazard models were utilized. Propensity-score matched analysis was employed to reduce confounding variables. RESULTS: A total of 3,136 patients met entry criteria: 2,252 (71.8%) received postoperative radiation, with 223 (7.4%) also receiving concurrent chemotherapy. Median follow-up was 4.87 years. In clinically lymph node negative (cN0) patients, 7.4% had pathologically positive lymph nodes (pN) + after elective neck dissection. Patients who lived closer to their treatment facility and had positive margins were more likely to receive postoperative radiation. Black patients and uninsured patients were less likely to receive radiation. Older age, male sex, advancing stage, and positive surgical margins were associated with worse overall survival (OS). With limited follow-up, receipt of radiation or chemotherapy was not associated with OS. CONCLUSION: Postoperative radiation was frequently given for resected ACC, with a minority receiving chemotherapy. Black patients and uninsured patients were less likely to receive radiation. Postoperative radiation and/or chemotherapy had no association with OS but were given in greater frequency in more advanced disease, and our series is limited by short follow-up. The disparity findings for this rare disease need to be addressed in future studies. LEVEL OF EVIDENCE: 2c Laryngoscope, 129:377-386, 2019.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Cassidy RJ, Switchenko JM, El-Deiry MW, et al. Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas. Laryngoscope. 2018. PMID: 30194768. doi:10.1002/lary.27302

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。